Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, discusses a study conducted with Takeda and the Harris Poll ...

Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

A blood-based test (Freenome) may provide a new option for colorectal cancer screening in the average-risk US population.

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...